A major challenge study finds top-performing AI models can detect breast cancer on screening mammograms with accuracy comparable to experienced radiologists.

AI model predicts delivery timing from ultrasound images with high accuracy, offering a potential tool for preterm birth risk assessment.

A new study reveals that group prenatal care leads to higher care attendance and better mental health during pregnancy compared to traditional one-on-one visits.

Panelists discuss how estrogen dosing selection depends on individual patient factors, including cycle control needs, noncontraceptive goals, estrogen sensitivity, age considerations for bone health, and patient comfort with hormone levels, with most providers using lower doses primarily to address estrogen-related adverse effects.

Panelists discuss how ideal candidates for combined hormonal contraceptives are those medically cleared for estrogen use who prefer predictable monthly periods, while progestin-only methods are recommended for patients with estrogen contraindications such as elevated body mass index (BMI) combined with older age or hypertension with migraines.

Study finds women 65+ experience sexual dysfunction at rates similar to midlife women but report less distress over sexual health concerns.

A new study reveals that adults born preterm face higher risks of mental health issues, high blood pressure, and metabolic problems.

Higher maternal vitamin D in early pregnancy linked to better fluid and overall cognition in children, especially among those of Black mothers.

Women in deprived neighborhoods face a 20% higher risk of gestational diabetes, underscoring the need for targeted public health interventions.

A new study finds higher rates of cyanotic congenital heart disease in states with abortion restrictions following the 2022 Supreme Court ruling.

FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients ≥12 years.

A new study reveals significant racial and ethnic differences in maternal and neonatal outcomes among physicians.

A new study finds women are significantly less likely to receive curative hepatitis C treatment than men while undergoing opioid use disorder care.

An expert discusses how elinzanetant demonstrated favorable body composition changes including weight loss, decreased fat mass index, and increased lean mass index in postmenopausal women.

An expert discusses how elinzanetant showed less bone mineral density decrease, reduced bone turnover markers, and increased total body bone density compared to placebo, suggesting beneficial skeletal effects.

A new study reveals long wait times, clinician shortages, and geographic gaps continue to delay diagnosis and treatment for patients with vulvar lichen sclerosus.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Panelists discuss how effective screening goes beyond formal tools like the Edinburgh Postnatal Depression Scale to include genuine patient connection, direct questioning about emotional well-being, and clinical observation, while emphasizing the important role pediatricians can play in identifying maternal mental health concerns during frequent baby visits.

Panelists discuss how reproductive psychiatry is an evolving subspecialty that requires collaboration between obstetricians, primary care providers, and psychiatrists, with clear guidelines for when to refer patients (such as those with bipolar history, psychosis, or treatment resistance) while building capacity for basic screening and treatment in obstetric settings.

A recent study found a decline in early-onset group B streptococcus infections and deaths in newborns after prenatal screening recommendations were updated in 2019.

Increasing daily sit-to-stand transitions lowered diastolic blood pressure in postmenopausal women, offering a simple strategy to support heart health.

A new study found that pregnant individuals with overweight or obesity are significantly less likely to meet recommended physical activity guidelines.

Panelists discuss how progestins have evolved from early norethindrone compounds through more potent but androgenic levonorgestrel to newer options such as drospirenone and dienogest, each offering different benefits for cycle control, noncontraceptive effects, and adverse effect profiles.

Panelists discuss how most combined hormonal contraceptives contain ethinyl estradiol for its long half-life and cycle control benefits, while newer natural estrogens such as estradiol and estetrol offer different tissue selectivity and potentially reduced liver impacts.

Data showed that fracture risk rises briefly after menopausal hormone therapy discontinuation, then falls below never-users.